Michael Redig
YOU?
Author Swipe
View article: Targeting CSF1R to overcome myeloid cell suppression in CART therapy
Targeting CSF1R to overcome myeloid cell suppression in CART therapy Open
Chimeric antigen receptor T (CART) cell therapy has shown unprecedented success in the treatment of hematological malignancies. However, the immunosuppressive tumor microenvironment of both solid and liquid tumors is a major barrier for CA…